The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment

by Mohammad Farhad, Annah S. Rolig, William L. Redmond
Published 2018-06-01

Editorial: Advances in Combination Tumor Immunotherapy

by Michael A Curran, Bernard A Fox, William L. Redmond
Published 2015-09-01

Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression.

by William L Redmond, Todd Triplett, Kevin Floyd, Andrew D Weinberg
Published 2012-01-01

OX40 agonists and combination immunotherapy: putting the pedal to the metal

by Stefanie N Linch, Michael J McNamara, William L. Redmond
Published 2015-02-01

Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers.

by Zhaoyu Sun, Richard Nyberg, Yaping Wu, Brady Bernard, William L Redmond
Published 2021-01-01

Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity

by Elizabeth R. Sturgill, Annah S. Rolig, Stefanie N. Linch, Courtney Mick, Melissa J. Kasiewicz, Zhaoyu Sun, Peter G. Traber, Harold Shlevin, William L. Redmond
Published 2021-01-01

The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumor.

by Marka R Crittenden, Talicia Savage, Benjamin Cottam, Keith S Bahjat, William L Redmond, Shelly Bambina, Melissa Kasiewicz, Pippa Newell, Andrew M Jackson, Michael J Gough
Published 2013-01-01

A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy

by Isaac Kim, Venkatesh Rajamanickam, Brady Bernard, Brie Chun, Yaping Wu, Maritza Martel, Zhaoyu Sun, William L. Redmond, Katherine Sanchez, Reva Basho, Heather McArthur, David B. Page
Published 2021-06-01

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

by William L Redmond, Yoshinobu Koguchi, Annah S Rolig, Noriko Iwamoto, Takashi Shimada, Elizabeth R Sturgill, Zhaoyu Sun, Venkatesh Rajamanickam, Brady Bernard, Peter G Traber, Eliezer Zomer, J Rex Horton, Harold Shlevin
Published 2021-04-01

Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer

by Katherine Sanchez, Isaac Kim, Brie Chun, Joanna Pucilowska, William L. Redmond, Walter J. Urba, Maritza Martel, Yaping Wu, Mary Campbell, Zhaoyu Sun, Gary Grunkemeier, Shu Ching Chang, Brady Bernard, David B. Page
Published 2021-01-01

A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

by Yiyi Chen, William L Redmond, Tomasz M Beer, Julie N Graff, Joshi J Alumkal, Rachel E Slottke, George V Thomas, Reid F Thompson, Mary A Wood, Emile Latour, Raymond C Bergan, Amy E Moran
Published 2020-07-01